27 October 2020 : Review article
Prognosis and Treatment of Liver Transplant Recipients in the COVID-19 Era: A Literature Review
Ashraf Imam1ADEFG, Sadi A. Abukhalaf1ABCDEF, Hadar Merhav1CDFG, Samir Abu-Gazala1ABDG, Oded Cohen-Arazi1BCEG, Alon Josef Pikarsky1DEFG, Rifaat Safadi2EFG, Abed Khalaileh1AEFG*DOI: 10.12659/AOT.926196
Ann Transplant 2020; 25:e926196
Table 4 Laboratory characteristics of all available reported liver transplant recipients infected with COVID-19.
| Study | Initial bilirubin (μmol/L) | Highest bilirubin | Initial WBC | Initial LC | Initial PLT | Initial CRP | Initial AST | Highest AST | Initial ALT | Highest ALT |
|---|---|---|---|---|---|---|---|---|---|---|
| Zhong | 38.9 | 103.7 | 2.46 | 0.48 | 74 | 122 | 240 | 424 | ||
| Liu | 5.9 | 0.42 | 32.1 | N | N | |||||
| Huang | 83.9 | 528.8 | 3.2 | 0.7 | 35.1 | 60 | ||||
| Qin | 0.64 | 132 | 80 | |||||||
| Morand | 3.2 | 120 | 224 | |||||||
| Lagana | 163 | 908 | 215 | 1253 | ||||||
| Kates | 1.93 | 0.9 | 39 | 12 | ||||||
| Hammami | 4.1 | 0.77 | 71 | 11 | 21 | 17 |